Skip to Content
Interactive Textbook on Clinical Symptom Research Logo


Home Button

 

Clinical Research on Dyspnea
Author Bios
What is Dyspnea?
What Provokes Dyspnea?
The Nature of Dyspnea
Language of Dyspnea
Clinical Application
Research Application
Variability in Sensations
Challenges in Study
Mechanical Loads and Sense of Effort
Chemoreceptors
Mechanoreceptors
Neuro-Mechanical Dissociation
Phase of Respiration and Dyspnea
Physiology of Dyspnea
Respiratory System
Cardiovascular System
Measuring Dyspnea
Scaling Issues
Qualitative Aspects
Reliability and Validity Overview
Reliability and Validity
Sensitivity and Specificity
Scales
Sensation vs. Perception vs. Symptom
Treating Dyspnea
Why Measure?
Cluster Analysis
Statistical vs. Clinical Significance
Standard Error of Measurement
Measuring Fatigue
Measuring Depression
Currently selected section: Measuring Anxiety and Hyperventilation
Measuring Quality of Life
Conclusion

 

Chapter 23: Dyspnea: Measuring Dyspnea-Related Anxiety and Hypertension
        

Anxiety is a frequent manifestation of pulmonary diseases and the prevalence of panic disorder is higher in patients with chronic lung disease than in matched, healthy controls (Smoller et al., 1996). The reverse is also true: patients with anxiety disorders frequently report symptoms of dyspnea, chest pain, palpitations, and a tingling or prickling sensation in the extremities (paresthesias). Patients experiencing an acute anxiety disorder may also experience hyperventilation with hypocapnia. Three models have been proposed to explain the relationship between dyspnea, hyperventilation, and anxiety disorders (Smoller et al., 1996).

Figure 32.1 Schematic Representation of Three Models of the Relationship between Dyspnea, Hyperventilation (HV), and Panic
Three models have been proposed to explain the relationship between dyspnea, hyperventilation, and anxiety disorders, described in text.
Official Journal of the American Thoracic Society. © American Lung Association. Reprinted with permission.

The hyperventilation model postulates that an increased ventilation leads to an acute respiratory alkalosis, the consequences of which are breathing discomfort and anxiety. The second model, a cognitive-behavioral model, suggests that individuals misinterpret physical sensations leading to a positive feedback cycle of anxiety leading to more symptoms leading to more anxiety. The third model proposes an abnormality in the central chemoreceptor such that a given stimulus leads to an over-exuberant response of the respiratory controller and an associated sense of dyspnea and panic/anxiety.

In patients with expiratory airflow obstruction, anxiety may also lead to a breathing pattern that precipitates physiological changes that can produce dyspnea. As respiratory rate rises, a common manifestation of anxiety, the patient with expiratory airflow obstruction has insufficient time to exhale. This leads to hyperinflation with an increased work of breathing and a sense of greater effort to breathe, and may be accompanied by the sensation of an "unsatisfying breath" . Breathing retraining techniques, commonly employed in pulmonary rehabilitation programs, are designed to break this cycle of rapid breathing, hyperinflation, more distress, and even faster, more shallow breaths. To the extent that one can provide the patient with strategies for dealing with their symptoms and attendant fears, the individual may establish a sense of control over his or her body that may pre-empt the development of anxiety and hyperventilation. Exercise training, by repeatedly exposing the patient to breathing discomfort under safe, monitored conditions, may also "desensitize" the patient to the fear associated with the sensations of dyspnea (Carrieri-Kohlman et al., 1996).


Page 45 of 47
      Previous Section